Custom Cell Line Development Service

About EverCyte

EverCyte is a Vienna-based biotech firm leveraging human telomerase (hTERT) immortalization to create standardized, long-lived human cell lines that mimic primary cell function. Its core business revolves around two pillars: providing these cells and derived extracellular vesicles as products for research, and offering contract services in cell line development, drug screening, and gene editing. The company positions itself as an enabler for more predictive preclinical testing and scalable production of therapeutic EVs, operating primarily as a B2B platform and service provider within the regenerative medicine and cell therapy sectors.

About Innoprot

Innoprot is a privately held, revenue-generating Spanish CRO and product company serving the global biopharma research sector. Its core business model combines the sale of specialized research products (like primary cells and engineered cell lines) with fee-for-service contract research, particularly in cell line development and phenotypic/target-based assay services. The company's technology focuses on creating advanced cellular models for drug discovery in areas such as oncology, CNS disorders, fibrosis, and metabolic diseases, positioning it as a specialized tools and services provider in the pre-clinical research space.

Therapeutic Areas